A retrospective serological survey on human babesiosis in Belgium

Lempereur, L., Shiels, B. , Heyman, P., Moreau, E., Saegerman, C., Losson, B. and Malandrin, L. (2015) A retrospective serological survey on human babesiosis in Belgium. Clinical Microbiology and Infection, 21(1), 96.e1-96.e7. (doi: 10.1016/j.cmi.2014.07.004) (PMID:25636942)

Full text not currently available from Enlighten.


In Europe, most clinical babesiosis cases in humans have been attributed to Babesia divergens and Babesia sp. EU1. Babesia microti infection of humans occurs mainly in the United States; although a case of autochthonous B. microti infection and serological evidence of infection have been reported in Europe. The Indirect Fluorescent Antibody Test was used to screen sera from 199 anonymous Belgian patients with history of tick bite and clinical symptoms compatible with a tick-borne disease. The serological screen detected positive reactivity in 9% (n = 18), 33.2% (n = 66), and 39.7% (n = 79) of the samples against B. microti, B. divergens, and Babesia sp. EU1, respectively. Thus, evidence of contact among three potentially zoonotic species of Babesia and humans has been confirmed in Belgium. Preventive action and development of better diagnostic tools should help in prevention of clinical cases and to clarify the true burden of such infection for individuals and public health.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Shiels, Professor Brian and Lempereur, Dr Laetitia
Authors: Lempereur, L., Shiels, B., Heyman, P., Moreau, E., Saegerman, C., Losson, B., and Malandrin, L.
College/School:College of Medical Veterinary and Life Sciences > Institute of Biodiversity Animal Health and Comparative Medicine
Journal Name:Clinical Microbiology and Infection
Publisher:Elsevier Ltd.
ISSN (Online):1469-0691

University Staff: Request a correction | Enlighten Editors: Update this record